Median Diagnostics Inc. (XKON:233250)
South Korea · Delayed Price · Currency is KRW 8,600.00
0.00 (0.00%)
At close: Apr 9, 2026
Median Diagnostics Market Cap
Median Diagnostics has a market cap or net worth of 15.02 billion as of April 10, 2026. Its market cap has decreased by -49.41% in one year.
Market Cap
15.02B
Enterprise Value
n/a
Revenue
7.86B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,600.00
Market Cap Chart
Since June 26, 2017, Median Diagnostics's market cap has decreased from 22.09B to 15.02B, a decrease of -32.02%. That is a compound annual growth rate of -4.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 15.02B | -25.09% |
| Dec 30, 2025 | 20.05B | -20.83% |
| Dec 30, 2024 | 25.32B | -9.32% |
| Dec 28, 2023 | 27.93B | -44.77% |
| Dec 29, 2022 | 50.56B | -27.35% |
| Dec 30, 2021 | 69.60B | -3.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 494.11B |
| 3billion | 380.82B |
| GENINUS | 160.24B |
| HLB Panagene | 108.90B |
| Cytogen | 93.20B |
| Green Cross Medical Science | 77.84B |
| Protia | 60.20B |
| Seoulin Bioscience | 53.40B |